Trial Update: "AI-Personalized Skincare Regimen" Study Completed Oct 19, 2026

A clinical trial involving acetyl hexapeptide-8, registered as NCT07879833, was reported as completed on October 19, 2026. The trial, titled "AI-Personalized Skincare Regimen for Facial Photoaging in Women," had no assigned phase, listed as NA. Its status in the registry now reads COMPLETED as of the stated date. No results, outcomes, or efficacy data were included in this update. The record does not indicate whether findings have been posted or published separately. Acetyl hexapeptide-8 is noted as an approved compound within its regulatory context. This update reflects only the trial's status change and does not describe any conclusions drawn from the study. Readers interested in the specifics of the trial design, participant criteria, or methodology should consult the official registry listing directly. As with any registry update, the completion status indicates the study has concluded its defined activities, not that results have been analyzed or released. Further updates may follow as the trial record is amended. For more background on acetyl hexapeptide-8, including its general profile and regulatory context, see the compound overview.